IP Library Granted Patent US 8,129,148
Granted Patent B2
US 8,129,148 · App. 12/064,810 · Granted Mar 6, 2012

Process for preparation of chondroitin fraction

Assignee: Seikagaku Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,129,148
App. No.
12/064,810
Granted
Mar 6, 2012
Kind
B2
Abstract

Provided are a method for producing a fraction containing more than 50% of CH represented by the general formula (1), which comprises at least the step of allowing a glucuronic acid donor, an N-acetylgalactosamine donor, a saccharide receptor, a chondroitin polymerase derived from the Escherichia coli K4 strain, and Mn 2+ at a final concentration of 0.02 to 100 mM to coexist, and performing a reaction thereof under conditions of 20 to 40° C. and pH 6 to 8 for 0.5 minutes to 4 hours, and a method for producing a fraction containing more than 50% of CH represented by the general formula (2), which comprises at least the step of performing the reaction under same conditions for 10 hours or longer, which enable industrial scale production of a CH fraction of a controlled even number saccharide and odd number saccharide content ratio by a simple procedure at a low cost. (GlcA-GalNAc) n   (1) GalNAc-(GlcA-GalNAc) n   (2) (In the formula, GlcA represents a glucuronic acid residue, GalNCAc represents a N-acetylgalactosamine residue, - represents a glycosidic bond, and n represents an arbitrary integer.)

Claims (16)

1. A method for producing a fraction comprising more than 50% of chondroitin represented formula (1), comprising the steps:

(a) reacting a glucuronic acid donor, a N-acetylgalactosamine donor, a saccharide acceptor, chondroitin polymerase derived from Escherichia coli K4, and Mn 2+ at a final concentration of 0.02 to 100 mM at 30° C. and pH 7.2 for 5 hours and measuring a chondroitin content ratio, X, in a fraction produced by the reaction, wherein the chondroitin content ratio, X, means a ratio of a number of chondroitin molecules represented by formula (1)/a number of chondroitin molecules represented by formula (2);

(b) determining a reaction time for providing the chondroitin content ratio, X, as determined in step (a) in a fraction produced when the reaction is performed under conditions of arbitrary temperature and pH, other than at 30° C. and pH 7.2, at which the chondroitin polymerase derived from Escherichia coli K4 can act for a reaction time defined to be Y; and

(c) performing the reaction at the same temperature and pH as step (b) for a time shorter than Y,

wherein formulae (1) and (2) are:

(GlcA-GalNAc) n   (1)

GalNAc-(GlcA-GalNAc) n   (2)

wherein GlcA represents a glucuronic acid residue, GalNac represents an N-acetylgalactosamine residue, - represents a glycosidic bond and n represents an arbitrary integer.

2. A method for producing a fraction comprising more than 50% of chondroitin represented by formula (2), comprising the steps of:

(a) reacting a glucuronic acid donor, a N-acetylgalactosamine donor, a saccharide acceptor, chondroitin polymerase derived from Escherichia coli K4, and Mn 2+ at a final concentration of 5 to 100 mM at 30° C. and pH 7.2 for 8 hours and measuring a chondroitin content ratio, X, in a fraction produced by the reaction, wherein the chondroitin content ratio, X, means a ratio of a number of chondroitin molecules represented by formula (1)/a number of chondroitin molecules represented by formula (2);

(b) determining a reaction time for providing the chondroitin content ratio, X, as determined in step (a) in a fraction produced when the reaction is performed under conditions of arbitrary temperature and pH , other than at 30° C. and pH 7.2, at which the chondroitin polymerase derived from Escherichia coli K4 can act for a reaction time defined to be Y; and

(c) performing the reaction at the same temperature and pH as step (b) for a time longer than Y,

wherein formulae (1) and (2) are:

(GlcA-GalNAc) n   (1)

GalNAc-(GlcA-GalNAc) n   (2)

wherein, GlcA represents a glucuronic acid residue, GalNAc represents an N-acetylgalactosamine residue, - represents a glycosidic bond, and n represents an arbitrary integer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 28, 2008
From: SUGIURA, NOBUO; KIMATA, KOJI
To: SEIKAGAKU CORPORATION
Reel/Frame 020594/0860 →
Priority Claims (2)
JP 2005-242272 · Aug 24, 2005 · national
JP 2006-205427 · Jul 27, 2006 · national
Continuity (1)
Related Publication 20090155851A1 · Jun 18, 2009